Clinical Trial Update: The Study of Dachengqi Decoction Combined With Probiotic L92 to Improve the Prognosis of Patients With Severe Abdominal Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial investigating Dachengqi Decoction combined with Probiotic L92 for improving prognosis in patients with severe abdominal hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Hypertension

Drugs mentioned

• Dachengqi Decoction (Dachengqi Decoction)
• Probiotic L92 (Lactobacillus rhamnosus GG (L92))

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Dachengqi Decoction, Probiotic L92 | Phase 2, Phase 3 | Status: UNKNOWN